Differential epithelial expression of the putative innate immune molecule SPLUNC1 in Cystic Fibrosis
2007

SPLUNC1 Levels in Cystic Fibrosis Lungs

Sample size: 20 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bingle Lynne, Barnes Frances A, Cross Simon S, Rassl Doris, Wallace William A, Campos Michael A, Bingle Colin D

Primary Institution: University of Sheffield

Hypothesis

SPLUNC1 expression is increased in the airways of patients with Cystic Fibrosis compared to non-CF lungs.

Conclusion

SPLUNC1 is significantly increased in the small airways of lungs from patients with Cystic Fibrosis, suggesting a defensive response from the airway epithelium.

Supporting Evidence

  • SPLUNC1 is one of the most highly expressed genes in the upper airways.
  • Increased SPLUNC1 levels were noted in the airways of patients with Cystic Fibrosis.
  • SPLUNC1 expression was not found in inflammatory cells in the CF lung.

Takeaway

In people with Cystic Fibrosis, a protein called SPLUNC1 is found in higher amounts in their lungs, which might help fight infections.

Methodology

Immunohistochemistry was used to localize SPLUNC1 in lung tissue from patients with CF and other lung diseases, complemented by molecular analysis of SPLUNC1 gene expression in primary human lung cell cultures.

Potential Biases

Potential bias due to the selection of patients with severe disease and the lack of demographic details.

Limitations

The study only included patients with severe CF at the time of lung transplantation, limiting the generalizability of the findings.

Participant Demographics

Patients with Cystic Fibrosis undergoing lung transplantation and patients with other lung diseases.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-8-79

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication